Ocugen (OCGN) Net Income towards Common Stockholders (QoQ) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -36.04% |
| Jun 30, 2025 | 3.98% |
| Mar 31, 2025 | 71.56% |
| Jun 30, 2023 | -27.89% |
| Mar 31, 2023 | 17.79% |
| Dec 31, 2022 | -0.08% |
| Sep 30, 2022 | -1.60% |
| Jun 30, 2022 | -13.38% |
| Mar 31, 2022 | -30.51% |
| Dec 31, 2021 | -35.57% |
| Sep 30, 2021 | 58.56% |
| Jun 30, 2021 | -266.71% |
| Mar 31, 2021 | -86.73% |
| Dec 31, 2020 | 63.82% |
| Sep 30, 2020 | 35.19% |
| Jun 30, 2020 | -309.75% |
| Mar 31, 2020 | -131.85% |
| Dec 31, 2019 | 154.37% |
| Sep 30, 2019 | -543.53% |
| Jun 30, 2019 | 62.33% |
| Mar 31, 2019 | -46.71% |
| Dec 31, 2018 | -88.20% |
| Sep 30, 2018 | 7.97% |
| Jun 30, 2018 | 74.27% |
| Mar 31, 2018 | -138.98% |
| Dec 31, 2017 | -18.37% |
| Sep 30, 2017 | 6.86% |
| Jun 30, 2017 | 6.48% |
| Mar 31, 2017 | 26.33% |
| Dec 31, 2016 | 14.27% |
| Sep 30, 2016 | -14.88% |
| Jun 30, 2016 | -1.52% |
| Mar 31, 2016 | 5.01% |
| Dec 31, 2015 | -3.19% |
| Sep 30, 2015 | -5.83% |
| Jun 30, 2015 | 4.16% |
| Mar 31, 2015 | -19.38% |
| Dec 31, 2014 | 44.29% |
| Sep 30, 2014 | -1.29% |
| Jun 30, 2014 | -128.53% |